Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy

Diabetes Care

Volumn 21, Issue 7, 1998, Pages 1076-1079

  Zelmanovitz, Themis ^a   Gross, Jorge L ^a   Oliveira, Jarbas ^a   De Azevedo, Mirela J ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; SCREENING TEST; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROTEINURIA; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0031871515     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.7.1076     Document Type: Article

References (20)

1. International Diabetes Federation, St. Vincent's Declaration, World Health Organization: Consensus Guidelines for the Management of Insulin-Dependent (Type 1) Diabetes. European IDDM Police Group, Eds. Bussum, The Netherlands, Medicom Europe, 1993
2. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH, Steffes MW, Striker GE: Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from Ad Hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25:107-112, 1995
3. Mogensen CE, Vestbo E, Poulsen PL, Christiansen C, Damsgaard EM, Eiskjaer H, Froland A, Hansen KW, Nielsen S, Pedersen MM: Microalbuminuria and the potential confounders: a renew and some observations on variability of urinary albumin excretion. Diabetes Care 18:572-581, 1995
4. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin creatinine ratio. J Am Soc Nephrol 7:1-8, 1996
5. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tarsch M, Azevedo MJ: The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 20:516-519, 1997
6. Mogensen CE, Keane WF, Bennet PH, Jerums G, Parving H-H, Passa P, Steffes MW, Striker GE, Viberti GC: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346: 1080-1084, 1995
7. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE: Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 306:1722-1725, 1993
8. Gazis A, Page SR: Microalbuminuria screening in the UK: are we meeting European standards? Diabet Med 13:764-767, 1996
9. Ireland JT, Viberti GC, Watkins PJ: The kidney and urinary tract. In Complications of Diabetes. 2nd ed. Keen H, Jarret J, Eds. London, Edward Arnold, 1982, p. 137-178
10. American Diabetes Association: Diabetic nephropathy (Position Statement). Diabetes Care 21 (Suppl. 1):S50-S53, 1998
11. Sasse EA, Doumas BT, Lemann J Jr: Diabetic nephropathy: urinary albumin or total protein? Ann Intern Med 111:343-344, 1989
12. Phillipou G, James SK, Seaborn CJ, Phillips PJ: Screening for microalbuminuria by use of a rapid, low-cost colorimetric assay. Clin Chem 35:456-458, 1989
13. Bradley M, Schumann GB, Ward PCJ: Examination of urine, In Clinical Diagnosis and Management by Laboratory Methods. 16th ed. Henry JB, Ed. Philadelphia, WB Saunders, 1979, p. 559-634
14. Centor RM: A Visicalc program for estimating the area under a receiver operating characteristic (ROC) curve. Med Decis Making 5:139-148, 1985
15. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36, 1982
16. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 148:839-843, 1983
17. Fletcher RH, Fletcher SW, Wagner EH: Diagnosis, In Clinical Epidemiology: The Essentials, 3rd ed. Baltimore, MD, Williams & Wilkins, 1996, p. 43-74
18. Carrie BJ, Golbetz HV, Michaels AS, Myers BD: Creatinine: an inadequate filtration marker in glomerular diseases. Am J Med 69:177-182, 1980
19. Payne RB: Creatinine clearance: a redundant clinical investigation. Ann Cin Biochem 23:243-250, 1986
20. Viberti GC, Mackintosh D, Keen H: Determinants of the penetration of proteins through the glomerular barrier in insulin-dependent diabetes mellitus. Diabetes 32 (Suppl. 2):92-95, 1983